Everolimus

Pancreatic Neuroendocrine Tumor

ExelixisSmall moleculePhase 4 / ApprovedActive

BBB

72/ 100

Provisional rating · Methodology v0.2

Rating breakdown

32 Active assets in the Pancreatic Neuroendocrine Tumor cohort.

Asset / Sponsor	Phase	Rating
Oxodotreotide University of Chicago	Phase 4	BBB
Irinotecan M.D. Anderson Cancer Center	Phase 2/3	BB
L-Cysteinamide, D-Phenylalanyl-L-Cysteinyl-L-Phenylalanyl-D-Tryptophyl-L-Lysyl-L-Threonyl-N-(2-Hydroxy-1-(Hydroxymethyl)Propyl)-, Cyclic (2->7)-Disulfide, (R-(R,R))- RayzeBio, Inc.	Phase 3	BB
Zanzalintinib Exelixis	Phase 3	BB
Capecitabine Gustave Roussy, Cancer Campus, Grand Paris	Phase 3	BB